Skip to main content
Erschienen in: Inflammation 4/2023

24.05.2023 | RESEARCH

Bioinformatic Analysis of the Potential Common Pathogenic Mechanisms for Psoriasis and Metabolic Syndrome

verfasst von: Yang Zhou, Lu Han, Ziting Wang, Runan Fang, Yue Wan, Zeyu Yang, Ning Guan, Jianhong Li, Qing Ni

Erschienen in: Inflammation | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

The pathogeneses of psoriasis and metabolic syndrome are closely related; however, the underlying biological mechanisms are yet to be clarified. A psoriasis training set was downloaded from the Gene Expression Omnibus database and analyzed to identify the differentially expressed genes (|logFC|> 1 and adjust P < 0.05). Differentially expressed genes for metabolic syndrome were obtained from the GeneCards, Online Mendelian Inheritance in Man, and DisGeNET databases, and crosstalk genes were obtained for multiple enrichment analysis after identifying the disease intersection. Characteristic crosstalk genes were screened using the least absolute shrinkage and selection operator regression model and random forest tree model, and the genes with area under the receiver operating characteristic curve > 0.7 were selected for validation by the two validation sets. Differential analyses of immune cell infiltration were performed on psoriasis lesion and control samples using the CIBERSORT and ImmuCellAI methods, and correlation analyses were performed between the screened signature crosstalk genes and immune cell infiltration. Significant crosstalk genes were analyzed based on the psoriasis area and severity index and on the responses to biological agents. We found five signature genes (NLRX1, KYNU, ABCC1, BTC, and SERPINB4) were screened based on two machine learning algorithms, and NLRX1 was validated. The infiltration of multiple immune cells in psoriatic lesions and non-lesions was associated with NLRX1 expression. NLRX1 was found to be associated with psoriasis severity and response rate after the use of biologics. NLRX1 could be a significant crosstalk gene for psoriasis and metabolic syndrome.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
6.
Zurück zum Zitat Shimobayashi, M., V. Albert, B. Woelnerhanssen, I.C. Frei, D. Weissenberger, A.C. Meyer-Gerspach, N. Clement, S. Moes, M. Colombi, J.A. Meier, M.M. Swierczynska, P. Jenö, C. Beglinger, R. Peterli, and M.N. Hall. 2018. Insulin resistance causes inflammation in adipose tissue. The Journal of Clinical Investigation 128: 1538–1550. https://doi.org/10.1172/JCI96139.CrossRefPubMedPubMedCentral Shimobayashi, M., V. Albert, B. Woelnerhanssen, I.C. Frei, D. Weissenberger, A.C. Meyer-Gerspach, N. Clement, S. Moes, M. Colombi, J.A. Meier, M.M. Swierczynska, P. Jenö, C. Beglinger, R. Peterli, and M.N. Hall. 2018. Insulin resistance causes inflammation in adipose tissue. The Journal of Clinical Investigation 128: 1538–1550. https://​doi.​org/​10.​1172/​JCI96139.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Soleimani, R., M. Mohammadi, S.A. Saghebi, A. Taghipour, A.K. Vakilzadeh, and J.T. Afshari. 2020. Comparison of Th1/Th2 and Treg/Th17 ratios between wet and dry cupping therapies in Persian medicine. Avicenna Journal of Phytomedicine 10: 24–34.PubMedPubMedCentral Soleimani, R., M. Mohammadi, S.A. Saghebi, A. Taghipour, A.K. Vakilzadeh, and J.T. Afshari. 2020. Comparison of Th1/Th2 and Treg/Th17 ratios between wet and dry cupping therapies in Persian medicine. Avicenna Journal of Phytomedicine 10: 24–34.PubMedPubMedCentral
14.
Zurück zum Zitat Kaneko, F., N. Itoh, H. Yoshida, M. Suzuki, and I. Ono. 1991. The cell-components and cytokines in the subcorneal microabscess of psoriasis. Fukushima Journal of Medical Science 37: 103–112.PubMed Kaneko, F., N. Itoh, H. Yoshida, M. Suzuki, and I. Ono. 1991. The cell-components and cytokines in the subcorneal microabscess of psoriasis. Fukushima Journal of Medical Science 37: 103–112.PubMed
28.
Zurück zum Zitat Li, S., P. Kang, W. Zhang, Z. Jian, Q. Zhang, X. Yi, S. Guo, W. Guo, Q. Shi, B. Li, P. Yuanmin He, L.L. Song, K. Li, G. Wang, T. Gao, and C. Li. 2020. Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo. The Journal of Allergy and Clinical Immunology 145: 632–645. https://doi.org/10.1016/j.jaci.2019.10.036.CrossRefPubMed Li, S., P. Kang, W. Zhang, Z. Jian, Q. Zhang, X. Yi, S. Guo, W. Guo, Q. Shi, B. Li, P. Yuanmin He, L.L. Song, K. Li, G. Wang, T. Gao, and C. Li. 2020. Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo. The Journal of Allergy and Clinical Immunology 145: 632–645. https://​doi.​org/​10.​1016/​j.​jaci.​2019.​10.​036.CrossRefPubMed
29.
31.
Zurück zum Zitat Costa, F.R., M.C. Françozo, G.G. de Oliveira, A. Ignacio, A. Castoldi, D.S. Zamboni, S.G. Ramos, N.O. Câmara, M.R. de Zoete, N.W. Palm, R.A. Flavell, J.S. Silva, and D. Carlos. 2016. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. The Journal of Experimental Medicine 213: 1223–1239. https://doi.org/10.1084/jem.20150744.CrossRefPubMedPubMedCentral Costa, F.R., M.C. Françozo, G.G. de Oliveira, A. Ignacio, A. Castoldi, D.S. Zamboni, S.G. Ramos, N.O. Câmara, M.R. de Zoete, N.W. Palm, R.A. Flavell, J.S. Silva, and D. Carlos. 2016. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. The Journal of Experimental Medicine 213: 1223–1239. https://​doi.​org/​10.​1084/​jem.​20150744.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Yang, Q., X. Jiean, Q. Ma, Z. Liu, V. Sudhahar, Y. Cao, L. Wang, X. Zeng, Y. Zhou, M. Zhang, X. Yiming, Y. Wang, N.L. Weintraub, C. Zhang, T. Fukai, W. Chaodong, L. Huang, Z. Han, T. Wang, D.J. Fulton, M. Hong, and Y. Huo. 2018. PRKAA1/AMPKalpha1-driven glycolysis in endothelial cells exposed to disturbed flow protects against atherosclerosis. Nature Communications 9: 4667. https://doi.org/10.1038/s41467-018-07132-x.CrossRefPubMedPubMedCentral Yang, Q., X. Jiean, Q. Ma, Z. Liu, V. Sudhahar, Y. Cao, L. Wang, X. Zeng, Y. Zhou, M. Zhang, X. Yiming, Y. Wang, N.L. Weintraub, C. Zhang, T. Fukai, W. Chaodong, L. Huang, Z. Han, T. Wang, D.J. Fulton, M. Hong, and Y. Huo. 2018. PRKAA1/AMPKalpha1-driven glycolysis in endothelial cells exposed to disturbed flow protects against atherosclerosis. Nature Communications 9: 4667. https://​doi.​org/​10.​1038/​s41467-018-07132-x.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Tattoli, I., L.A. Carneiro, M. Jéhanno, J.G. Magalhaes, Y. Shu, D.J. Philpott, D. Arnoult, and S.E. Girardin. 2008. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Reports 293–300. https://doi.org/10.1038/sj.embor.7401161. Tattoli, I., L.A. Carneiro, M. Jéhanno, J.G. Magalhaes, Y. Shu, D.J. Philpott, D. Arnoult, and S.E. Girardin. 2008. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Reports 293–300. https://​doi.​org/​10.​1038/​sj.​embor.​7401161.
39.
Zurück zum Zitat Novoszel, P., M. Holcmann, G. Stulnig, C. De Sa Fernandes, V. Zyulina, I. Borek, M. Linder, A. Bogusch, B. Drobits, T. Bauer, C. Tam-Amersdorfer, P.M. Brunner, G. Stary, L. Bakiri, E.F. Wagner, H. Strobl, and M. Sibilia. 2021. Psoriatic skin inflammation is promoted by c-Jun/AP-1-dependent CCL2 and IL-23 expression in dendritic cells. EMBO Molecular Medicine e12409. https://doi.org/10.15252/emmm.202012409. Novoszel, P., M. Holcmann, G. Stulnig, C. De Sa Fernandes, V. Zyulina, I. Borek, M. Linder, A. Bogusch, B. Drobits, T. Bauer, C. Tam-Amersdorfer, P.M. Brunner, G. Stary, L. Bakiri, E.F. Wagner, H. Strobl, and M. Sibilia. 2021. Psoriatic skin inflammation is promoted by c-Jun/AP-1-dependent CCL2 and IL-23 expression in dendritic cells. EMBO Molecular Medicine e12409. https://​doi.​org/​10.​15252/​emmm.​202012409.
Metadaten
Titel
Bioinformatic Analysis of the Potential Common Pathogenic Mechanisms for Psoriasis and Metabolic Syndrome
verfasst von
Yang Zhou
Lu Han
Ziting Wang
Runan Fang
Yue Wan
Zeyu Yang
Ning Guan
Jianhong Li
Qing Ni
Publikationsdatum
24.05.2023
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 4/2023
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-023-01815-4

Weitere Artikel der Ausgabe 4/2023

Inflammation 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.